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a  b  s  t  r  a  c  t
The  high  prevalence  of  cardiovascular  diseases  (CVD)  demands  a reliable  and  sensitive  risk  assessment
technique.  In  order  to  develop  a fast and label-free  immunosensor  for  C-reactive  protein  (CRP),  a  risk
factor for  this  condition,  anti-CRP  antibodies  were  physically  adsorbed  to  the  hydrogen  (H)-terminated
surface  of nanocrystalline  diamond  (NCD).  An  Enzyme-Linked  ImmunoSorbent  Assay  (ELISA)  reference
technique  showed  that  this  was  a  suitable  substrate  for antibody–antigen  recognition  reactions.  Electro-
chemical  Impedance  Spectroscopy  (EIS)  was  used  to  electronically  detect  CRP  recognition.  The  speciﬁcity
of the  immunosensor  was  demonstrated  by incubation  with  CRP  and  plasminogen  as  reference  molecule.
A  different  impedance  behavior  was  observed  in  real-time  after  CRP  addition  as  compared  to  plasmino-
gen  addition:  the  impedance  increased  only  during  CRP  incubation.  Fitting  the  data  showed  that  thismpedance spectroscopy
anocrystalline diamond
eal-time detection
corresponded  with  a  decrease  in capacitance  of  the  molecular  layer  due  to  its  increased  thickness  by
speciﬁc CRP  recognition.  Sensitivity  experiments  in  real-time  showed  a  clear  discrimination  between
1  M,  100  nM,  and  10 nM  of  CRP  after  10  min  at 100  Hz.  Since,  10 nM  of  CRP  was  still  clearly  distinguish-
able  from  buffer  solution,  our  CRP-directed  immunosensor  prototype  reaches  a  sensitivity  that  is  within
the  physiologically  relevant  concentration  range  of  this  biomarker  in  healthy  controls  and  CVD  patients.
Moreover,  this  prototype  displayed  real-time  discriminating  power  between  spiked  and  unspiked  serum,
pplicaand  thus  also  shows  its  a
. Introduction
C-reactive protein (CRP) is an acute phase protein that is pro-
uced in the liver. In its native form, it is a pentamer of 126 kDa,
onsisting of ﬁve identical monomers of 25 kDa each. Its serum level
ncreases rapidly during systemic inﬂammation, where it assists
n complement binding to foreign and damaged cells. Through
his mechanism, phagocytosis is enhanced by macrophages, which
xpress a receptor for CRP. There is also evidence that CRP increases
he expression of the cell adhesion molecules ICAM-1, VCAM-1 and
-selection in cultured endothelial cells [1].  Therefore, CRP has tra-
itionally been used as a reliable marker for tissue injury, infection,
nd inﬂammation. However, studies have shown that CRP is also
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implicated in the development of cardiovascular diseases (CVD),
such as atherosclerosis, angina, coronary heart disease, peripheral
artery disease, myocardial infarction, and stroke [2].  Not only can
elevated blood levels of CRP predict the recurrence of coronary
events in patients with stable or unstable angina [2],  but also it
can even determine an increased risk for hypertension [3] and CVD
in healthy controls [4].  CRP serum levels of <8 nM are considered
normal, while levels >25 nM indicate an increased risk for CVD. As
a result, CRP can serve as an important risk assessment factor for
the development of cardiovascular diseases [4].
The most recent statistics from the American Heart Associ-
ation report that in 2006, 80 million Americans suffered from
CVD, of whom 829,072 actually died [5].  It is estimated that 2400
Americans die of CVD each day [6].  Hence, the need for reliable
and sensitive risk assessment is obvious. Over the years, many
assay methods for the detection of CRP have been developed and
improved, such as latex agglutination, nephelometry, turbidime-
try, and ﬂuorescent polarization [7].  Currently, an Enzyme-Linked
ImmunoSorbent Assay (ELISA)-based blood test called the ‘highly
sensitive C-reactive protein (hs-CRP) assay’ is available to deter-
mine CVD risk (Dade Behring, Inc., now Siemens Medical, IL,
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SA). Its limit of detection is 0.8 nM (0.1 g ml−1). However, dis-
dvantages of ELISA tests are the long reaction times (several
ours) of the multiple steps involved, and the requirement of
rained personnel and expensive reagents [8].  A Surface Plas-
on  Resonance (SPR) biosensing platform for CRP was developed
y Hu et al., where anti-CRP antibodies were bound to a gold
Au) surface through Protein G. They reached a detection limit
f 8 nM (1 g ml−1) of puriﬁed CRP [8].  Meyer et al. also estab-
ished an immunosensor for CRP detection based on SPR. The
etection principle was based on two different anti-CRP anti-
odies: one for CRP entrapment and one for labeling. A linear
etection range of 16–40 nM (2–5 g ml−1) CRP in PBS buffer
as found [9].  Recently, the same authors developed a novel
RP detection method in crude serum, urine, and saliva sam-
les based on magnetic detection. With its linear detection range
rom 0.2 nM (25 ng ml−1) to 20 nM (2.5 g ml−1), it showed to
e even more sensitive than the hs-CRP ELISA assay [10]. In
he last years, the focus on Electrochemical Impedance Spec-
roscopy (EIS)-based immunosensing methods for various targets
as increased signiﬁcantly. These impedimetric immunosensors
re usually based on capacitive changes or changes based on
harge-transfer resistance. Cooreman et al. investigated the inter-
ction between the semiconducting polymer poly[2-methoxy-5-
3,7-dimethyloctyloxy)]-1,4-phenylenevinylene (MDMO-PPV) and
hysically adsorbed antibodies against the ﬂuorescent dyes FITC
nd Cy5. Speciﬁc antigen–antibody recognition was  demonstrated
ased on EIS. These antibody-modiﬁed polymer ﬁlms show a clear
esponse to 9 nM of antigen solution, with a time constant of
–3 min  [11]. Ionescu et al. devised an impedimetric Au-based
mmunosensor against the antibiotic ciproﬂoxacin. A detection
imit of 80 fM (10 pg ml−1) was reached [12]. Yang et al. used EIS to
irectly detect antigen–antibody binding. They covalently bound
uman IgG and IgM, serving as antigens, to aldehyde-terminated
anocrystalline diamond (NCD) surfaces using a glyceraldehyde
rosslinker. The antibodies were detected in real-time using anti-
gG and anti-IgM [13]. In this study, we will adsorb monoclonal
nti-CRP antibodies onto hydrophobic H-terminated NCD, allow-
ng CRP recognition to occur through a typical antigen–antibody
nteraction via the hypervariable regions of anti-CRP, adding clin-
cal relevance to our immunosensor setup in comparison with the
ork of Yang et al. [13].
Diamond has been studied as a novel transducer material for
iosensor fabrication because of very appealing physical, optical,
hemical and electrical characteristics. For a complete overview,
he reader is referred to the works of Field and Swain [14,15].
mong others, it has a wide electrochemical window, and, although
n insulator with a very wide band gap of 5.5 eV, it can be
ade electrically conductive by chemical doping [16–18].  These
lectrical properties of diamond have already been exploited in
he construction of diamond-based ﬁeld-effect transistors (FET)
sing technologies that are compatible with lithographic meth-
ds [19,20]. Moreover, diamond is biocompatible, allowing in vivo
pplications [21] and it can be functionalized with biomolecules.
lthough diamond is chemically inert, Takahashi et al. surmounted
his barrier by the photochemical activation of H-terminated
iamond surfaces [22]. The way was paved towards further modi-
cation of diamond with biomolecules, such as DNA and proteins.
owadays, also wet chemical [23], electrochemical [24–26],  and
hotochemical [25–30] methods exist to functionalize diamond
urfaces. The reader is referred to the article of Wenmackers for
n extensive review on functionalization and read-out techniques
f DNA on diamond [31]. In our previous work, it was  demon-
trated that real-time differentiation between fully complementary
nd 1-mismatch DNA was possible on lightly boron (B)-doped
anocrystalline diamond (NCD) substrates using EIS [32]. In order
o achieve a more generic, ﬂexible biosensor platform, this sameuators B 157 (2011) 130– 138 131
NCD- and EIS-based setup was  developed in an immunosensing
application.
2. Materials and methods
2.1. Materials
Sulfuric acid (H2SO4) was obtained from VWR  International
(Zaventem, Belgium). Potassium nitrate (KNO3) was acquired
from Merck (Overijse, Belgium). Coating buffer (0.014 M Na2CO3,
0.035 M NaHCO3, 0.003 M NaN3), Phosphate Buffered Saline (10×
PBS: 1.29 M NaCl, 0.05 M Na2HPO4·2H2O, 0.015 M KH2PO4, pH
7.2) and CRP buffer (20 mM  TRIS-buffer, pH 8, containing 0.28 M
NaCl, 0.09% NaN3 and 5 mM CaCl2) were homemade. Bovine Serum
Albumin (BSA) was bought from Roche Diagnostics (Vilvoorde,
Belgium). An ELISA ampliﬁcation system based on the cyclic redox
reaction of NADH/NAD+ was  obtained from Invitrogen (Merel-
beke, Belgium). Unlabeled and alkaline phosphatase (AP)-labeled
anti-CRP monoclonal antibodies, their speciﬁc antigen CRP, and
plasminogen for the speciﬁcity experiments were synthesized by
Scipac (Kent, United Kingdom). Human serum is obtained by cen-
trifuging whole blood from a healthy donor at 4000 rpm for 15 min
at 5 ◦C. Quantiﬁcation of the CRP levels was  performed in Labo Rigo
(Genk, Belgium) by a turbidimetric assay, which indicated a CRP
concentration well below 4 nM.
2.2. NCD synthesis and functionalization
Lightly B-doped H-terminated NCD was synthesized by
microwave plasma enhanced chemical vapor deposition in a way
previously described [28,32,33].  Also, commercial NCD samples
from rho-BeSt Coatings (Innsbruck, Austria, order no. HASTPO43)
were used. The comparability of biosensing experiments on IMO
NCD samples and commercially available H-terminated NCD sam-
ples from rho-BeSt was  already demonstrated in previous studies
[28,32]. Thus, these two types of samples were used interchange-
ably.
Unlabeled anti-CRP monoclonal capture antibodies were diluted
in coating buffer until a concentration of 20 nM was  reached. The
H-terminated NCD samples were immersed in this anti-CRP solu-
tion and incubated for 2 h at 37 ◦C to allow physisorption of the
antibodies. The anti-CRP-coated NCD samples were subsequently
incubated overnight in a 6% BSA solution in 1× PBS at 4 ◦C to block
the remainder of the NCD surface that was  not coated with anti-CRP.
Also, H-terminated NCD samples treated only with 6% BSA but
without anti-CRP antibodies were used as a control.
2.3. Reference ELISA procedure to verify the functionality of the
adsorbed antibodies
To verify the formation of the anti-CRP/CRP-complex, 20 nM of
unlabeled anti-CRP capture antibodies and 6% BSA were coated on
two  H-terminated NCD samples using the method described in Sec-
tion 2.2.  One NCD sample was  subsequently incubated with 2.4 M
of CRP, while the other was treated with CRP buffer without CRP.
After 2 h of reaction, detection occurred through the incubation
with 70 mM  AP-labeled anti-CRP antibodies in conjugation buffer
for 1 h, and a subsequent substrate reaction using an ELISA ampli-
ﬁcation system based on NADPH. This substance is transformed by
AP to NADH, which is the substrate for a secondary enzymatic redox
cycle. Diaphorase oxidizes NADH to NAD+ while reducing a tetra-while ethanol is oxidized by alcohol dehydrogenase, NAD+ is again
reduced to NADH, driving the cyclic behavior of the ampliﬁcation
reaction. After 1–2 min, the reaction liquid was removed from the
surface of the NCD samples with a micropipette, and transferred
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tig. 1. Schematic diagram of the immunosensor setup used in the experiments. Th
easurement of four conditions.
dopted from [33].
nto the wells of a microtiter plate. This microtiter plate was sub-
equently placed inside an ELISA reader, and the absorption of the
olored product was measured at 405 nm.
To examine the adsorption of CRP molecules and AP-labeled
nti-CRP antibodies to unmodiﬁed NCD, two H-terminated sam-
les that were not coated with anti-CRP but only blocked with 6%
SA were also treated with CRP and CRP buffer, respectively.
.4. Sensor setup
The sensor setup devised for the development of a CRP-sensitive
mmunosensor is displayed in Fig. 1. Four separate NCD samples
f 1 cm2 coated with anti-CRP antibodies, functioning as working
lectrodes, were mounted on a copper (Cu) back contact using sil-
er (Ag) paste. Rubber O-rings with a diameter of 6 mm and an
crylic glass lid containing circular openings of equal size were
ressed onto the samples to create four reaction wells above the
CD samples.
Each well was ﬁlled with 140 l of reaction ﬂuid. Au wires,
laced ∼1 mm  above each NCD surface and in contact with the
eaction ﬂuid, were used as counter-electrodes. Ag/AgCl electrodes
ere also tested. However, noise was lowest using Au. Working
nd counter-electrodes were connected to the impedance analyzer
ith shielded cables. Hence, four signals were recorded simultane-
usly.
.5. Electrochemical Impedance Spectroscopy (EIS)
EIS was performed using a Hewlett Packard 4194A
mpedance/Gain-Phase Analyzer (Agilent, Diegem, Belgium).
he impedance is measured by applying an AC potential (U) of
0 mV  to the measurement cell. The response to this potential is
n AC current signal (I). The complex impedance (Z) was measured
or 50 frequencies, equidistant on a logarithmic scale, in a fre-
uency range from 100 Hz to 1 MHz. The duration of one complete
requency sweep per channel was 8 s. A Keithley 7001 switch card
Keithley Instruments, B.V., Sint-Pieters-Leeuw, Belgium) was  used
o switch between the four channels after each frequency sweep.
Real-time impedance curves from anti-CRP-functionalized
r BSA-functionalized NCD samples mounted into the above
escribed setup were recorded continuously during stabilization
n buffer before antigen addition, antigen addition, and rinsing. The
eaction wells were ﬁrst ﬁlled with pure (1×  or 0.1×)  PBS buffer, and
he device was allowed to stabilize until the difference in Z betweensor houses four anti-CRP-functionalized NCD samples, allowing the simultaneous
two  successive frequency sweeps was negligible throughout the
entire frequency range.
For the speciﬁcity experiments, 72 pmol (500 nM) of either CRP
or plasminogen was  then added to the PBS buffer, and allowed to
react for 1 h. Plasminogen (81 kDa) is present in blood, making it
a good competitor molecule. When converted into its active form
plasmin, it plays an important role in wound healing. After the reac-
tion, the reaction wells were rinsed and reﬁlled with pure (1×  or
0.1×) PBS buffer.
For the sensitivity analysis, 14.4, 1.44, and 0 pmol (100, 10, 0 nM)
of CRP, diluted in CRP buffer, was  added to the PBS buffer. After the
reaction, the reaction wells were rinsed and reﬁlled with pure (1×
or 0.1×)  PBS buffer.
For the serum measurements, spiked and unspiked serum was
added to pure serum to a ﬁnal concentration of 72 pmol (500 nM)  of
CRP. After the reaction, the reaction wells were rinsed and reﬁlled
with pure serum.
Experiments were performed at 37 ◦C, by placing the sensor
setup inside a humidity-controlled oven, which also provided elec-
tromagnetic shielding.
2.6. Statistical analysis
The signiﬁcance of the impedance behavior during serum mea-
surements was  determined using Student’s t-test.
3. Results and discussion
3.1. Reference ELISA procedure to verify the functionality of the
adsorbed antibodies
To verify the suitability of H-terminated NCD as a substrate
for the physisorption of anti-CRP, as well as the functionality of
these adsorbed antibodies, two H-terminated NCD samples were
coated with 20 nM unlabeled anti-CRP antibodies and 6% BSA, as
described above. To examine the non-speciﬁc adsorption of CRP
and AP-labeled anti-CRP antibodies to diamond, two  additional H-
terminated samples were only coated with 6% BSA. For both NCD
couples (anti-CRP-coated and BSA-coated H-terminated NCD), one
sample was treated with CRP, while the other was  incubated with
CRP buffer. The negative control samples (coated or uncoated with
anti-CRP) treated with CRP buffer, provided insight in the non-
speciﬁc adsorption of AP-labeled anti-CRP antibodies to coated or
uncoated NCD. The negative control sample that was not coated
V. Vermeeren et al. / Sensors and Actuators B 157 (2011) 130– 138 133
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Fig. 3. Determination of the speciﬁcity of the CRP-directed immunosensor. (A) The
real-time behavior of the impedance at 100 Hz during the total course of the exper-
iment. The impedance values have been normalized to the value at the start of the
ﬁrst addition of proteins (t = 0). (B) Nyquist plot showing the impedance for the 50
frequencies at the start of the ﬁrst CRP addition () and at the end of the second CRPig. 2. Colorimetric measurements of differently functionalized NCD samples, dis-
laying the efﬁciency of the antibody/antigen-complex formation and the amount
f  non-speciﬁc adsorption of CRP and AP-labeled anti-CRP.
ith anti-CRP but was treated with CRP indicated the amount of
on-speciﬁc CRP adsorption to NCD. Detection occurred with an
P-labeled anti-CRP antibody and an AP-based substrate reaction.
he absorption of the colored product was determined at 405 nm.
t was clear that the absorption is the highest for the sample allow-
ng the formation of the antibody/antigen-complex, with minimal
ontributions due to non-speciﬁc adsorption (Fig. 2). H-terminated
CD was therefore considered a suitable substrate for antibody
dsorption, as the biological functionality of the antibodies are
etained.
.2. Speciﬁcity of the immunosensor
The speciﬁcity of the sensor was investigated by comparing the
nﬂuence of 72 pmol CRP with that of 72 pmol plasminogen on the
mpedance behavior of anti-CRP functionalized NCD samples.
.2.1. Nyquist plots and real-time immunosensing
Real-time immunosensing experiments were performed as fol-
ows. The wells were ﬁrst ﬁlled with 140 l of 1× PBS, after which
he impedance signal was allowed to stabilize. At the time cor-
esponding to t = 0, CRP was added to the ﬁrst two wells, while
lasminogen was added to the third and fourth well, ensuring that
ll ﬁnal antigen concentrations were 500 nM.  After 80 min, the four
ells were rinsed three times with pure 1× PBS buffer. In order
o check for the presence of free antibodies on the NCD surface
hat was still available for antigen recognition after this procedure,
nd also to investigate the reliability of the sensing method, the
ddition of proteins was repeated as before. Fig. 3A illustrates a
ypical real-time behavior of the impedance at 100 Hz during such
n experiment.
Note that the start of the ﬁrst antigen treatment, immediately
fter the ﬁrst antigen addition to the buffer (t = 0), can be regarded
s an internal reference point, corresponding to a condition where
one of the antibodies have recognized their antigen. This allows
he events in each channel to be evaluated relative to this point.
ence, the impedance in each channel has been normalized to this
nternal reference point.
In all of the channels, the direct effect of protein addition is
n immediate steep impedance increase of ∼5%. After 80 min, the
mpedance has increased with 20% in the ﬁrst well treated with
RP (open squares) and with 10% in the second well treated with
RP (open triangles), with respect to t = 0. A small decrease of
2% with respect to t = 0 after the initial impedance increase was
bserved in the wells where plasminogen was  added (full sym-
ols).
During the second antigen recognition phase, both CRP channels
o longer show the clear increase in impedance after the initial riseaddition (). (C) Nyquist plot showing the impedance for the 50 frequencies at the
start of the ﬁrst plasminogen addition () and at the end of the second plasminogen
addition (). The full lines indicate ﬁts to an equivalent circuit.
as observed during the ﬁrst protein addition, indicating that most of
the anti-CRP antibodies recognized their CRP targets during the ﬁrst
reaction. However, they have now reached an increase of more than
25% from the reference point t = 0, possibly due to extensive ionic
redistribution in the molecular layer during the rinsing steps. The
channels where plasminogen was added show the same behavior
during both additions.
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Fig. 3B and C shows the Nyquist plots of this experiment at the
eference point t = 0 (full squares) and at the end of the second
rotein addition (open squares) of one CRP- and one plasminogen-
reated channel, respectively. It is obvious that the impedance at
ow frequencies has increased during the CRP recognition (Fig. 3B).
uring plasminogen incubation (Fig. 3C), a completely different
ehavior is observed. The impedance has decreased over the fre-
uency range from 100 Hz to 1000 Hz. The results for the remaining
hannels are similar (data not shown).
.2.2. Fitting the results
In order to get more insight in the physical meaning of the
mpedance variations, the Nyquist plots of Fig. 3B and C were ana-
yzed using equivalent circuit models. This was  done using the
SimpWin software from Princeton Applied Research (MA, USA).
he ﬁts were performed over the total frequency range from 100 Hz
o 1 MHz. For most of the data, good ﬁts (2 ∼ 4 × 10−4) could be
btained by using the model circuit given in Fig. 4, and they are
llustrated by the full lines in Fig. 3B and C.
The circuit can be divided into three components: (a) the solu-
ion resistance Rs, between the Au electrode and the NCD surface,
b) a resistance RQ1 and a constant phase element Q1 in parallel, cor-
esponding to the molecular layer and its associated double-layer
n the surface, (c) a resistance RQ2 and a constant phase element Q2
n parallel, corresponding to the space-charge region in the NCD.
he impedance of a Q element is deﬁned by Z = [Q(iw)n]−1. For our
ata, n varied between 0.7 and 1. A value of n = 1 is equivalent to
 ‘perfect’ capacitor. A value of n = 0.5 corresponds to a Warburg
mpedance [34]. The parameter values obtained for the ﬁts shown
n Fig. 3B and C are indicated in Table 1.
From the ﬁt results it can be seen that the increase of
he impedance at low frequencies (100–1000 Hz) during CRP-
reatment in Fig. 3B corresponds with a signiﬁcant decrease of
he Q1 value with 42 ± 7%. This was consistently observed, and
ndicates a smaller capacity for the molecular layer after CRP recog-
ition at the surface. The additional layer of CRP antigens on top of
he anti-CRP antibodies increases the thickness of the molecular
ayer and changes its dielectric properties, decreasing its capaci-
ance.
However, in the well where plasminogen was added, only the
ther parallel element R2Q2, reﬂecting the space–charge region of
he NCD, shows signiﬁcant changes. The constant phase element
2 decreases with 70 ± 5%. It should be mentioned that this large
ecrease of Q2 was not consistently observed for all plasminogen
dditions. However, what was observed in each experiment for
he reference channel (CRP buffer addition, plasminogen addition,
SA-coated NCD), is a slight decrease of the total impedance at low
requencies, as illustrated in the following section.
.3. Reliability of the immunosensorIn order to get more insight in the reliability of the immunosen-
or, we performed a variation on the speciﬁcity measurements. The
ffect of antigen addition on H-terminated NCD samples function-
lized with anti-CRP was compared with H-terminated NCD coatedFig. 5. Real-time impedance spectra taken at 100 Hz. (A) The effect of 500 nM plas-
minogen addition on bare NCD and NCD functionalized with anti-CRP. (B) The effect
of  500 nM CRP addition to the same samples after rinsing and stabilization.
with BSA. A typical result of such an experiment is illustrated in
Fig. 5 where the normalized impedance at 100 Hz is given.
After stabilization, ﬁrst plasminogen was added to the wells, so
that the ﬁnal concentration in the wells was 500 nM.  The resulting
effect is given in Fig. 5A. After the typical initial impedance increase,
there was a decrease of ∼2 and 6% with respect to t = 0 for both NCD
types, comparable to the effect observed in Fig. 3A.
In a second step, and after rinsing, CRP was  added to these wells
in a ﬁnal concentration of 500 nM.  As can be seen in Fig. 5B, CRP
addition has the characteristic increasing effect only on the NCD
sample functionalized with anti-CRP (open triangles), associated
with a decrease in molecular layer capacitance. The level of this
increase, however, is slightly smaller than in Fig. 3A.
3.4. Sensitivity of the immunosensor
A clear effect on the impedance is also reproducibly observed
in real-time when exposing the anti-CRP-modiﬁed H-terminated
NCD samples to different concentrations of CRP. Fig. 6A shows a
typical result of experiments where 14.4 pmol of CRP, 1.4 pmol of
CRP, and pure CRP buffer were added to 140 l of 0.1× PBS buffer
in wells 1, 2, and 3, respectively. The ﬁnal CRP concentrations in
these three wells then corresponded to 100 nM,  10 nM and 0 nM,
respectively. Real-time impedance spectra were taken at 100 Hz.
The impedance at 100 Hz changes in a concentration-dependent
manner. The different impedance spectra, corresponding to the dif-
ferent CRP concentrations, can be clearly distinguished from each
other within 40 min. The impedance of the reference channel (open
circles) shows a characteristic decrease, while the impedance of
the channel with a CRP concentration of 100 nM (open squares) is
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Table 1
Results of ﬁtting the impedance spectra at the start of the ﬁrst and at the end of the second addition of CRP and plasminogen.
Element CRP Plasminogen
Start End Signiﬁcant effect (%) Start End Signiﬁcant effect (%)
Rs () 69.7 ± 1.3a 66.2 ± 0.8 −5 ± 2 74.1 ± 1.9 81 ± 4 +9 ± 6
Q1 (S sn) 0.48 ± 0.05 0.279 ± 0.015 −42 ± 7 1.3 ± 0.3 1.7 ± 0.7 –
n  0.77 ± 0.02 0.78 ± 0.01 – 0.71 ± 0.03 0.69 ± 0.06 –
R1 ()  und.b und. – und. und. –
Q2 (nS sn) 12.1 ± 0.9 13 .3 ± 0.7 – 21.2 ± 1.9 6.2 ± 0.9 −70 ± 5
n  0.96 ± 0.01 0.95 ± 0.01 – 0.89 ± 0.01 0.96 ± 0.01 +7 ± 2
R2 (k) 1.31 ± 0.04 1.28 ± 0.04 – 7.8 ± 0.4 7.8 ± 0.3 –
a Reported uncertainties are standard deviations as obtained from the data ﬁts.
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learly increasing, and shows a comparable behavior to the effect
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ig. 6. Concentration-dependent sensitivity of the sensor for CRP. (A) Real-time
mpedance spectra at 100 Hz of different concentrations of CRP. (B) Calibration plot
epresenting the relative effect on Z after 40 min  for different concentrations of
RP.  The black line shows the relative effect on Z for 0 nM of CRP (pure CRP buffer)
nd the gray box delineates the standard deviation. The data are generated from 3
ndependent measurements.y the fact that R1 is the value of the real part of the impedance, extrapolated from
Fig. 3B and C, only the start of this new semi-circle is visible in the corresponding
ever, already starts to show a slight decrease, indicating a lower
density of antigen/antibody-complexes, and approaching the con-
dition of non-recognition, also seen with buffer and plasminogen
treatment. Fig. 6B shows a calibration for concentrations varying
from 1 nM (or ∼1.25 g ml−1) to 1000 nM.  The data represent the
mean value and standard deviation for the change in Z after 40 min
of CRP treatment. The mean value and standard deviation for pure
CRP buffer (0 nM CRP) is indicated by the full line and shaded area,
respectively. From this curve it is clear that 10 nM,  was  the low-
est concentration that could reproducibly be discriminated from
buffer. This limit of detection was  comparable to the work described
by Hu et al. [8],  who could detect 8 nM (1 g ml−1) of puriﬁed CRP,
and even slightly better than the work described by Meyer et al. [9],
who  reached a detection limit of 16–40 nM (2–5 g ml−1) of puri-
ﬁed CRP. All of these studies were done in real-time, with results of
our group and Hu et al. [8] being obtained in the minute-scale, while
an experiment of Meyer et al. [9] takes about 3 h. However, further
improvements are needed to reach and exceed that of the hs-CRP
assay and that of Meyer et al. [10] in crude samples. However, these
are endpoint assays.
The real-time impedance spectra observed at 100 Hz
(Figs. 3A, 5 and 6A)  indicate that, when comparing the sam-
ple channel to a reference channel in the same measurement, a
good discrimination between the two  conditions is obtained after
40 min  of reaction. However, because of the good reproducibility
of the sensor, it is also possible to compare the sample channels
of separate measurements. This is illustrated in Fig. 7, where the
CRP-dependent impedance curve (black squares) is the average of
5 independent impedance measurements at 100 Hz on anti-CRP
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ndependent impedance measurements at 100 Hz on anti-CRP
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eviations. It can be seen that, after 25 min, the two types of curves
igniﬁcantly diverge, and obtain a range of values speciﬁc for
eference and sample. The rise in impedance remains consistently
haracteristic for the speciﬁc CRP recognition.
.5. Serum
To investigate the immunosensor’s suitability to detect CRP
n a complex and clinically relevant matrix, the reaction wells
ere ﬁrst ﬁlled with 140 l of pure human serum. After stabi-
ization of the impedance signal, spiked serum was  added so that
he ﬁnal CRP concentration was 500 nM (t = 0). For the negative
ontrol, the same volume of unspiked human serum was added.
ig. 8 shows the average of 6 independent impedance measure-
ents at 100 Hz on anti-CRP functionalized samples in human
erum.
The negative control shows the typical decrease in impedance
ignal. The spiked serum causes a characteristic impedance
ncrease of 1.6% after 30 min. As compared to the measurements
n buffer, shown in Fig. 7, the impedance effect is slightly less,
robably due to the high complexity of the medium. However,
ifference in impedance behavior between spiked and unspiked
erum was signiﬁcant (p > 0.045), indicating that real-time and
abel-free detection of CRP is possible in human serum.
It should be remarked that, in comparison to our impedimet-
ic experiments on DNA-functionalized NCD samples [32], the
tabilization of the immunosensor impedance signal after the dis-
urbance of the system by pipetting manipulations takes longer.
his increased stabilization time can be attributed to the fact
hat the DNA probes were covalently bound to the NCD through
atty acid linker molecules, whereas the antibodies were phys-
cally adsorbed to H-terminated NCD. Some degree of gradual
issociation and re-adsorption of the antibodies from and to the
urface can therefore not be excluded, resulting in a dynamic
olecular layer. It has been reported that covalently attaching
he receptor molecules to a surface signiﬁcantly decreases sig-
al drift as compared to physically adsorbed receptor molecules
35].uators B 157 (2011) 130– 138
4. Conclusions
In this work, the potential of EIS on H-terminated NCD is
demonstrated for the development of a real-time and label-
free immunosensor. The suitability of this diamond substrate for
functional antibody adsorption was  demonstrated with an ELISA
reference technique. In this study a speciﬁc discrimination between
CRP and plasminogen was obtained in real-time at low frequencies
(100 Hz).
Speciﬁc CRP recognition by the physisorbed anti-CRP antibod-
ies was consistently associated with an increase in impedance,
due to a decreased capacitance of the molecular layer caused by
CRP binding. The level of increase varied between 5 and 20%. On
the other hand, non-speciﬁc conditions, either by the addition
of plasminogen or buffer to anti-CRP functionalized NCD or the
use of BSA-coated NCD, were characterised by a small impedance
decrease at 100 Hz of ∼5%.
The sensitivity of the immunosensor was analyzed by incubating
the NCD samples with different concentrations of CRP. At 100 Hz,
the lowest concentration of CRP used in our experiments (10 nM)
was  still clearly distinguishable from the reference channel treated
with buffer within 20 min. This indicates the possibility that our
prototype immunosensor for CRP can reach sensitivity within the
physiologically relevant concentration range, important to discrim-
inate between healthy controls (8–10 nM)  and patients at risk for
CVD (>10 nM).
Preliminary serum measurements were also performed, and
showed that the impedimetric immunosensor was capable of sig-
niﬁcantly distinguishing between spiked and unspiked serum. The
applicability of the sensor in a real biological matrix displays gen-
uine clinical relevance, and will allow for its use as a point-of-care
diagnostic device.
For future experiments, a covalent attachment between anti-
body and NCD is recommended to decrease the stabilization time
of the impedance signal.
Another point of improvement is the miniaturization of the sen-
sor setup. This will likely result in a decrease of the reaction time
through its effects on diffusion and double-layer disturbances. First
of all, decreasing the reaction volume will signiﬁcantly decrease
the diffusion time of the antigens to the surface. Secondly, this
smaller reaction volume will likely shorten the relaxation time of
the double-layer after disturbances.
Furthermore, the analysis of frequencies below 100 Hz, which
will be even more sensitive to events in the molecular layer, will
increase the reproducibility of the magnitude of the impedance
effects during recognition of different concentrations of CRP.
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